Key Details
Price
$5.49Annual ROE
-29.84%Beta
1.95Events Calendar
Next earnings date:
Feb 21, 2025Recent quarterly earnings:
Nov 6, 2024Recent annual earnings:
Feb 22, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
SALT LAKE CITY , Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.
Despite positive demand and fundamentals, I believe the market undervalues HCAT's growth potential. Gross margin contraction is due to temporary headwinds, which should ease, leading to strong margin expansion. Risks include potential delays in growth acceleration and macroeconomic uncertainties.
SALT LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation on Wednesday, January 15, 2025, at 10:30 am PT. The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com.
SALT LAKE CITY , Nov. 20, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of an AI-powered version of BluePrint Protect™ from Intraprise Health, LLC ("Intraprise Health"), a platform that empowers healthcare organizations to screen and identify risks related to cybersecurity threats through third parties. On Nov. 6, Health Catalyst announced it signed a definitive agreement to acquire Intraprise Health, a tech-enabled cybersecurity provider offering an end-to-end cybersecurity risk management platform and services to protect healthcare clients from cyberattacks and manage follow-on liability in the event of an incident.
SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Stephens Annual Investment Conference, being held in Nashville, including a fireside chat on Wednesday, November 20, 2024, at 1:00 pm CT.
Health Catalyst, Inc. (NASDAQ:HCAT ) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO Dan LeSueur - COO Jason Alger - CFO Conference Call Participants Jared Haase - William Blair Jessica Tassan - Piper Sandler Anna Kruszenski - Barclays Bank John Pinney - Canaccord Genuity Thomas Kelliher - RBC Capital Markets David Larsen - BTIG John Ransom - Raymond James Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Operator Welcome to the Health Catalyst Third Quarter 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.
While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Health Catalyst (HCAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:
Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.
FAQ
- What is the ticker symbol for Health Catalyst?
- Does Health Catalyst pay dividends?
- What sector is Health Catalyst in?
- What industry is Health Catalyst in?
- What country is Health Catalyst based in?
- When did Health Catalyst go public?
- Is Health Catalyst in the S&P 500?
- Is Health Catalyst in the NASDAQ 100?
- Is Health Catalyst in the Dow Jones?
- When was Health Catalyst's last earnings report?
- When does Health Catalyst report earnings?
- Should I buy Health Catalyst stock now?